No posts to display
Top News
Celltrion Files for European Approval of Cosentyx Biosimilar, Targets $6.7 Billion...
Celltrion has filed for European approval of its CT-P55 biosimilar for autoimmune diseases, aiming for early market entry and expansion.
- Our Sponsors Ad -